XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Assets and Liabilities Measured at Fair Value - Narrative (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]      
Contingent consideration     $ 21,417
Callidus Biopharma Inc      
Business Acquisition [Line Items]      
Contingent consideration $ 15,000 $ 9,000